STOCK TITAN

10x Genomics Insider Notice: 9,228 Shares Proposed Sale via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

10x Genomics (TXG) Form 144 notice: The filing reports a proposed sale of 9,228 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $123,747.48, and an approximate sale date of 08/22/2025 on NASDAQ. The securities were acquired as a Restricted Stock Unit grant on 08/21/2025 totaling 25,785 shares, with payment characterized as services rendered. The filer discloses one prior sale in the last three months: Serge Saxonov sold 9,343 shares on 05/22/2025 for $77,540.36. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

  • Disclosure completeness: Filing names broker, share counts, acquisition details, prior sale and sale date, meeting Rule 144 requirements
  • Acquisition origin stated: Securities identified as an RSU grant with payment as services rendered, clarifying basis for sale

Negative

  • Insider sale planned: Proposed sale of 9,228 shares (aggregate market value $123,747.48) indicates insider liquidity activity
  • Recent prior sale: Seller reported a sale of 9,343 shares on 05/22/2025 for $77,540.36

Insights

TL;DR: Routine insider notice disclosing an upcoming sale of RSU-derived shares; no earnings or material corporate events included.

The Form 144 documents a proposed sale of 9,228 shares tied to a Restricted Stock Unit grant received one day earlier (08/21/2025). The filing identifies the executing broker and provides the aggregate market value and planned sale date, satisfying Rule 144 disclosure requirements. The presence of a prior sale by the same individual within three months is disclosed. There are no itemized financial results, new contracts, or regulatory actions in this filing to suggest material impact on company fundamentals.

TL;DR: Filing meets insider disclosure standards; shows a recent RSU grant followed by a planned sale and prior recent disposition.

The notice transparently links the securities to a Restricted Stock Unit grant and records the method of payment as services rendered, which clarifies transfer origin. It names the broker, sale amount, and prior sale by Serge Saxonov, fulfilling transparency expectations for insider transactions. This is a compliance-oriented disclosure without governance actions or changes in management disclosed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TXG Form 144 disclose about the planned sale?

The notice reports a proposed sale of 9,228 common shares via Morgan Stanley Smith Barney, aggregate market value $123,747.48, with an approximate sale date of 08/22/2025 on NASDAQ.

How were the shares being sold acquired?

The securities were acquired as a Restricted Stock Unit grant on 08/21/2025; the filing lists 25,785 shares from that grant and notes payment as services rendered.

Did the filer sell other TXG shares recently?

Yes. The filing discloses a prior sale by Serge Saxonov of 9,343 shares on 05/22/2025, generating gross proceeds of $77,540.36.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC Executive Services located at 200 W Civic Center Dr., Sandy, UT; the sale is to occur on NASDAQ.

Does the filing state whether the seller has undisclosed material information?

Yes. By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.